Edwards HM. Aetlogy and treatment of severe postpartum haemorrhage. Dan Med J. 2018 Mar;65(3):B5444. Deneux-Tharaux C, Morau E, Dreyfus M; pour le Cnemm. [Maternal mortaly France 2013-2015: An evolvg profe]. Gynecol Obstet Fert Senol. 2021 Jan;49(1):1-2. do 10.1016/j.gofs.2020.12.002. No abstract avaable. French. Henruez DDCA, Caram-Deelder C, le Cess S, Zwart JJ, van Roosmalen JJM, Eenboom JCJ, So-Osman C, van de Waterg LMG, Zwagga JJ, Koopman-van Gemert AWMM, Bloemenkamp KWM, van der Bom JG; TeMpOH-1 Research Group. Assoctn of Tg of Plasma Transfusn Wh Adverse Maternal Outcomes Women Wh Perstent Postpartum Hemorrhage. JAMA Netw Open. 2019 Nov 1;2(11):e1915628. do 10.1001/jamanetworkopen.2019.15628. Henruez DDCA, Bloemenkamp KWM, Loeff RM, Zwart JJ, van Roosmalen JJM, Zwagga JJ, van der Bom JG; TeMpOH-1 study group. Flu resuscatn durg perstent postpartum haemorrhage and maternal outcome: A natnwe cohort study. Eur J Obstet Gynecol Reprod Bl. 2019 Apr;235:49-56. do 10.1016/j.ejogrb.2019.01.027. Epub 2019 Feb 4. Clinical Use and Outcome of NovoSeven® Treatment in Severe Postpartum Haemorrhage - Experiences From an Observational Multi-country (UK, DK, FR, NL) Retrospective Cohort Study